5Richard BP.Cancer pain management an essential component of comprehensive cancer care In:Philip R.Clinical oncology [M].北京:人民卫生出版社,2002:865.
6Non-small cell lung cancer collaborative gronp.Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trial[J].BMI, 1995, 311(7010):899.
7Stran P.Cancer relaterad smarta kraver fiktad behandling analgetka Inte enda behind-ling sahernativet,[Cancer-related pain requires targeted treatment].analgesics are not the only therapeutic alternative[J]. Lakartidningen, 1999,96(4):318.
8Luckman SP, Hughes DE, CoxonFP, et al.Nitrogen2contain2ing bisphosphonates inhibit the mevalonate pathway and prevent post2translational prenylation of GTP2bingding proteins ineluding[J].Ras J Bone Miner Res, 1998,13:581.
9Rogers M J, Gordon S, Benford HL, et al.Cellular and molec2ular molecular mechanisms of action of bisphophonates[J].Cancer, 2000, 88(Suppl) : 2961.
10Rosen, Gordon D, Tchekmedyian S, ct al.Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors:A phase m ,double2 blind,randomized trial.The Zoledronic Acid l,ung Cancer and Other Solid Tumors Study Group[J].J Clin Onco1,2003,21:3150.
